In the open field test, mice with PD tended to spend less time in exploring the central part of the open field arena, and FGF21 treatment significantly increased the spontaneous activity in the central part of the arena (P < 0.001, Figures 1D,E). This evidence concerns the gene FGF21 and Parkinson disease.